Biogen (BIIB) Income from Non-Controlling Interests (2009 - 2023)

Biogen (BIIB) has reported Income from Non-Controlling Interests for 13 consecutive years, with -$800000.0 the latest figure, recorded in Q4 2023.

• In Q4 2023, Income from Non-Controlling Interests rose 11.11% year-over-year to -$800000.0; the TTM figure through Sep 2024 stood at -$800000.0 (down 366.67% YoY), while the FY2023 annual figure was $400000.0, up 100.47% from the prior year.
• Income from Non-Controlling Interests came in at -$800000.0 for Q4 2023 at Biogen, down from -$200000.0 in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was $577.0 million in Q2 2021, with the low at -$388.7 million in Q4 2021.
• Average Income from Non-Controlling Interests over 4 years is $9.2 million, with a median of -$300000.0 recorded in 2020.
• The largest YoY upside for Income from Non-Controlling Interests was 795.96% in 2021 against a maximum downside of 129466.67% in 2021.
• Year by year, Income from Non-Controlling Interests stood at -$300000.0 in 2020, then tumbled by 129466.67% to -$388.7 million in 2021, then surged by 99.77% to -$900000.0 in 2022, then grew by 11.11% to -$800000.0 in 2023.
• According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$800000.0, -$200000.0, and $1.7 million for Q4 2023, Q3 2023, and Q2 2023 respectively.